Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in CGON — CG Oncology, Inc.

CIK 861177 NEW YORK, NY

Position in CGON

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$54,126,383
-$17,950,512 QoQ
Shares Held
761,807
-28.5% QoQ
Ownership
0.859%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 226 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 43% Shared 0% None 57%

Common Shares in CGON Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. CGON ranks #17 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CGON

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $54,126,383 761,807
2026-03-31 $72,076,895 1,064,966
2025-12-31 $45,293,916 1,090,894
2025-09-30 $31,430,564 780,302
2025-06-30 $22,271,522 856,597
2025-03-31 $4,392,599 179,363
2024-12-31 $3,610,868 125,902
2024-09-30 $796,933 21,122
2024-06-30 $745,840 23,625